Package 67046-1648-3

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 67046-1648-3
Digits Only 6704616483
Product NDC 67046-1648
Product ID 67046-1648_48726fc1-9885-0f7e-e063-6394a90a8905
Description

30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (67046-1648-3)

Marketing

Marketing Status
Marketed Since 2026-01-15
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48726fc1-9885-0f7e-e063-6394a90a8905", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["487271f1-c956-086a-e063-6394a90a2dc7"], "manufacturer_name": ["Coupler LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (67046-1648-3)", "package_ndc": "67046-1648-3", "marketing_start_date": "20260115"}], "brand_name": "Bupropion hydrochloride", "product_id": "67046-1648_48726fc1-9885-0f7e-e063-6394a90a8905", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "67046-1648", "generic_name": "Bupropion hydrochloride", "labeler_name": "Coupler LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA215568", "marketing_category": "ANDA", "marketing_start_date": "20260115", "listing_expiration_date": "20271231"}